Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.93 |
| ▸ | EYA2 | O00167 | 1/20 | 0.93 |
| ▸ | APP | P05067 | 1/20 | 0.93 |
| ▸ | ACE | P12821 | 1/20 | 0.93 |
| ▸ | BLM | P54132 | 2/20 | 0.88 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.88 |
| ▸ | TSHR | P16473 | 2/20 | 0.88 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.88 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.88 |
| ▸ | LMNA | P02545 | 1/20 | 0.88 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.88 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.88 |
| ▸ | DRD1 | P21728 | 1/20 | 0.88 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.88 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.88 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.88 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.88 |
| ▸ | DRD3 | P35462 | 1/20 | 0.88 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.88 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.88 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Edetic Acid SCHEMBL4287868 | 1.00 | TDP1 (0.93) | TDP1EYA2APPACEBLM | |
| Edetic Acid SCHEMBL537771 | 1.00 | TDP1 (0.93) | TDP1EYA2APPACEBLM | |
| Edetic Acid SCHEMBL120660 | 1.00 | TDP1 (0.93) | TDP1EYA2APPACEBLM | |
| Edetic Acid SCHEMBL59497 | 1.00 | TDP1 (0.93) | TDP1EYA2APPACEBLM | |
| Edetic Acid SCHEMBL1512912 | 0.97 | TDP1 (0.88) | TDP1EYA2APPACEBLM | |
| Edetic Acid SCHEMBL21483279 | 0.97 | TDP1 (0.88) | TDP1EYA2APPACEBLM | |
| Edetic Acid SCHEMBL4956709 | 0.97 | TDP1 (0.88) | TDP1EYA2APPACEBLM | |
| Edetic Acid SCHEMBL21483277 | 0.97 | TDP1 (0.88) | TDP1EYA2APPACEBLM | |
| Edetic Acid SCHEMBL7209772 | 0.97 | TDP1 (0.88) | TDP1EYA2APPACEBLM | |
| Edetic Acid SCHEMBL1535300 | 0.97 | TDP1 (0.88) | TDP1EYA2APPACEBLM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 414 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250332118-A1 | NOVEL ORAL CARE FORMULATIONS FOR TREATMENT OF XEROSTOMIA | LIVIONEX INC (US) | 2025-10-30 | — | — | US | claimed |
| EP-4637688-A1 | ORAL CARE COMPOSITIONS | Colgate-Palmolive Company (US) | 2025-10-29 | — | — | EP | claimed |
| US-20250222110-A1 | METHODS AND COMPOSITIONS FOR TREATMENT OF AGE-RELATED CATARACTS | LIVIONEX INC (US) | 2025-07-10 | — | — | US | claimed |
| US-12324871-B2 | Absorbable iron-based alloy implanted medical device and manufacturing method thereof | BIOTYX MEDICAL (SHENZHEN) CO., LTD. (CN) | 2025-06-10 | — | — | US | claimed |
| CN-119453173-A | Urine protective agent and application thereof | 北京清华长庚医院 | 2025-02-18 | — | — | CN | claimed |
| EP-4504163-A1 | NOVEL ORAL CARE FORMULATIONS FOR TREATMENT OF XEROSTOMIA | Livionex, Inc. (US) | 2025-02-12 | — | — | EP | claimed |
| CN-119384274-A | Novel oral care formulations for the treatment of xerostomia | 利维昂尼克斯公司 | 2025-01-28 | — | — | CN | claimed |
| CN-115430526-B | Composite inhibitor, flotation reagent and method for reverse flotation dephosphorization of phosphorus-containing lithium ore | 广州聚源矿业科技有限公司 | 2024-11-12 | — | — | CN | claimed |
| WO-2024173395-A1 | ORAL CARE COMPOSITIONS | COLGATE-PALMOLIVE COMPANY (US) | 2024-08-22 | — | — | WO | claimed |
| WO-2023196667-A1 | NOVEL ORAL CARE FORMULATIONS FOR TREATMENT OF XEROSTOMIA | LIVIONEX, Inc. (US) | 2023-10-12 | — | — | WO | claimed |
| WO-1999064548-A1 | SHOWER RINSING COMPOSITION | THE CLOROX COMPANY (US) | 1999-12-16 | — | — | WO | claimed |
| US-5972876-A | COMPRISING ANIONIC, NONIONIC SURFACTANTS, AND MIXTURES THEREOF, A QUATERNARY AMMONIUM SURFACTANT, WATER-SOLUBLE OR DISPERSIBLE SOLVENT COMPRISING ALKANOLS, DIOLS, GLYCOL ETHERS; ETHYLENEDIAMINETETRAACETIC ACID, TETRAPOTASSIUM SALT | CLOROX COMPANY, THE | 1999-10-26 | — | — | US | claimed |
| US-5948741-A | MIXTURE OF SURFACTANTS, SOLVENTS, CHELATING AGENT, PROPELLANT AND WATER | THE CLOROX COMPANY (US) | 1999-09-07 | — | — | US | claimed |
| EP-0937125-A1 | LOW ODOR, HARD SURFACE CLEANER WITH ENHANCED SOIL REMOVAL | The Clorox Company (US) | 1999-08-25 | — | — | EP | claimed |
| WO-1998044080-A1 | AEROSOL HARD SURFACE CLEANER WITH ENHANCED SOIL REMOVAL | THE CLOROX COMPANY (US) | 1998-10-08 | — | — | WO | claimed |
| WO-1998016606-A1 | LOW ODOR, HARD SURFACE CLEANER WITH ENHANCED SOIL REMOVAL | THE CLOROX COMPANY (US) | 1998-04-23 | — | — | WO | claimed |
| US-4595527-A | Chelating agent, ethoxylated phenol or fatty alcohol or ester nonionic surfactant with HLB of 9-13, water | S. C. JOHNSON & SON, INC. (US) | 1986-06-17 | — | — | US | claimed |
| US-4530781-A | Metastable prespotting composition | S. C. JOHNSON & SON, INC. (US) | 1985-07-23 | — | — | US | claimed |
| EP-0137474-A2 | Metastable prespotting composition | S.C. JOHNSON & SON, INC. (US) | 1985-04-17 | — | — | EP | claimed |
| EP-0137475-A2 | Aqueous laundry prespotting composition | S.C. JOHNSON & SON, INC. (US) | 1985-04-17 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250332118-A1 | NOVEL ORAL CARE FORMULATIONS FOR TREATMENT OF XEROSTOMIA | STOM, TAS2R40, SLC14A1 | TDP1 228/4885EYA2 1778/4885APP 4586/4885 |
| US-20250222110-A1 | METHODS AND COMPOSITIONS FOR TREATMENT OF AGE-RELATED CATARACTS | MSMO1, SLC16A8, SMS | TDP1 3882/4885EYA2 279/4885APP 3400/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.